The identification of pathogenic mechanisms relevant to these patients ... Every year, roughly 700 people in Finland develop diffuse large B-cell lymphoma. The most common symptom is enlarged ...

Dr. Hosoya says, "Although a few case reports of laryngeal edema with tisa-cel treatment for B-cell lymphoma have appeared, the mechanism of this phenomenon is still unknown and no established ...

The following is a summary of “A real-world pharmacovigilance assessment and literature review of lymphoma development in ...

The investigation demonstrated that dual targeting of DOT1L and EZH2 effectively prevented human GCB-DLBCL xenograft growth in vivo. According to the authors, GCB-DLBCLs exhibit strong dependence on ...

About a third of patients with diffuse large B cell lymphoma (DLBCL), a fast-growing ... has been working to understand the underlying mechanisms of the targeted chemotherapy venetoclax.

A study led by University of Cincinnati Cancer Center researchers sheds new light on the mechanisms by which a major oncogene ...

When your doctor talks to you about your B-cell lymphoma, they'll tell you what type you have. It's an important piece of info to get, because each type of this cancer acts differently and has its ...

Bantam Pharmaceutical, a drug discovery and development company targeting selective modulation of mitochondrial dynamics in ...